Collection of biological samples from patients with autoimmune skin diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive collection of biological and clinical data from patients suffering from autoimmune, dysimmune, or auto-inflammatory dermatological diseases. By gathering blood samples and other biological materials, the study seeks to identify new biomarkers that could lead to innovative therapeutic strategies. The research focuses on understanding the complex mechanisms behind these diseases, which affect a significant portion of the adult population, particularly women. The findings will be made accessible to the medical and scientific communities to enhance diagnostic and treatment options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin.

The patients included may be adults or children, and will be:

* Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),
* Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),
* Patients with cutaneous lupus
* Patients with dysimmune skin diseases (psoriasis, eczema)
* Patients with immuno-induced dermatological disorders or drug dermatitis
* Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.).

Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected

Exclusion Criteria:

* Patients under protective supervision (guardianship, curators)
* Patients under 6 years old
* Pregnant or breastfeeding woman

Where it's running

• University Hospital
  Toulouse, France Recruiting

Study contacts

• Principal investigator: Chloé BOST, MD, PhD — University Hospital, Toulouse
• Study coordinator: Chloé BOST, MD, PhD
• Email: bost.c@chu-toulouse.fr
• Phone: 5 61 77 61 44

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Does driving with UVA exposure affect facial skin hydration on the left vs right cheek in Florida drivers

  This observational study tests whether Florida women who drive more show less hydration on their left cheek (exposed to UVA through the driver-side window) compared with their right cheek.

  Recruiting IAS Skin Care · Orlando, Florida · NCT07764809

• Topical KB111 for Hailey-Hailey Disease (early phase, kids and adults)

  This study tests whether a topical KB111 treatment is safe and helps with lesions in people with Hailey-Hailey disease, including adolescents and adults.

  Recruiting Early Phase 1 Krystal Biotech, Inc. · Miami, Florida · NCT07717346

• Turning anonymous symptom descriptions into structured biological signals with OpenGenome

  This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.

  Recruiting OpenGenome · Friedrichshain, State of Berlin · NCT07578610

• Safety of BG-A3004 in healthy volunteers and people with immune-mediated skin diseases

  This study will test whether single and multiple doses of the experimental drug BG-A3004 are safe and how the body handles it in healthy adults and people with immune-mediated skin diseases.

  Recruiting at 11 sites Phase 1 BeOne Medicines · Beijing, Beijing Municipality and 10 other locations · NCT07412691

• Detailed profiling of chronic inducible urticaria (symptomatic dermographism and cold urticaria)

  This project will test whether detailed biological and skin measurements can find markers to help diagnose and predict treatment response in adults with symptomatic dermographism or cold urticaria.

  Recruiting at 2 sites Centre for Human Drug Research, Netherlands · Leiden, South Holland and 2 other locations · NCT07359430

• Skin reactions from chest implantable port dressings

  This study will see how often dressings on chest implantable ports cause skin reactions in adults starting first-line chemotherapy.

  Recruiting Institut Curie · Paris and 2 other locations · NCT07158879

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.